Welcome to

the International Max Planck Research School for Heart and Lung Research


PhD studies in the Heart of Europe

 

The International Max Planck Research School for Heart and Lung Research (IMPRS-HLR) is the leading educational platform of the Max Planck Institute in Bad Nauheim, Germany.

 

 

The mission of the IMPRS-HLR is to provide state-of-the-art training in biomedicine and to conduct cutting edge research in order to gain new insights into the basic molecular mechanisms that underlie cardiovascular and lung diseases and to translate this knowledge into new individualized therapies for vascular and parenchymal heart and lung diseases. IMPRS-HLR is jointly operated by the Justus Liebig University (Gießen), the Goethe University (Frankfurt), as well as the Max Planck Institute for Heart and Lung Research (Bad Nauheim). 

 

The structured curriculum of the school offers interdisciplinary lectures, workshops, method and career development seminars as well as the participation in international conferences and annual retreats. The international and interdisciplinary approach of the program promotes cross-frontier thinking, communication and scientific networking.

 

In contrast to the broad PhD program, the conducted research thesis is focused on the scientific interest of the chosen research group at the MPI for Heart and Lung Research, at the Justus Liebig University (Gießen) or at the Goethe University (Frankfurt). Doctoral students can choose from PhD projects in the field of heart, vessel and lung biology and research of our IMPRS faculty covers high-level science in development, remodeling and regeneration, stem cell biology, developmental genetics and translational research. The combination of specialized knowledge and interdisciplinary education within our PhD program provides an excellent foundation for a future career.

 

Our Mission

 

Research & Faculty

 

The Ph.D graduate program

 

Application

The deadline for applications has now passed.

No more applications can be accepted.

The evaluation process starts now and applications will receive a notification about the outcome by Mid-April latest.

© 2019 Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany